Charles River - JP Morgan Conference Presentation
Comprehensive C> capabilities
In high-growth, high-science cell and gene therapy sector
Research Models &
Services
- Immunodeficient rodent models
Cellular products used as inputs in
research, process development,
and manufacture of cell therapies
Microbial Solutions
- Advanced rapid screening
technologies
Charles River - JP Morgan Conference Presentation
Discovery Services
"Combo" pharmacology and
safety studies collaborating
across multiple DSA sites
Safety Assessment
Bioanalytical, immunogenicity, and
biodistribution, and GLP toxicology
assessments performed across
multiple SA sites
Extensive Portfolio Spanning Cell & Gene Therapies
Biologics Testing
- Analytical efficacy/safety
testing for viral gene therapy or
viral vector
C> CDMO
- CGMP cell therapy manufacturing
Plasmid DNA and viral vector
production for gene therapies
17View entire presentation